Background Severe aortic valve stenosis (AS) is a major cause of morbidity and mortality
worldwide. The definitive management for severe AS is aortic valve replacement (AVR). The …

Background: Transfemoral access is the standard approach for transcatheter aortic valve
replacement (TAVR). However, an important proportion of TAVR patients may not be …

Background Aortic stenosis is prevalent among older adults and is commonly treated with
transcatheter aortic valve replacement. Both high-and low-risk patients benefit from early …

Background Aortic valve stenosis (AS) is a growing health problem worldwide, especially in
elderly populations. 1 Its severity is classified by a number of clinical and echocardiographic …

Objective: To compare the post-operative complication rate in Transcatheter Aortic Valve
Implantation [TAVI] vs Surgical Aortic Valve Replacement [SAVR] within one week of the …

Objective The experience of safe extubation in the operating room (OR) after transcatheter
aortic valve implantation (TAVI) procedure remains not well established. The authors …

The advent of percutaneous therapies has significantly altered therapeutic options for
patients with valvular heart disease. Building on the success of transcatheter aortic valve …

Care of patients undergoing transcatheter heart valve (THV) procedures has evolved
dramatically over the last decade. Post-procedure care has moved from recovery following a …

Background Patients with underlying interstitial lung disease (ILD) who undergo cardiac
surgery are at high risk of postoperative pulmonary complications. It remains unclear if …

WO2020097723A1 - Apple peel polyphenol extract for the prevention and the treatment of
non-alcoholic fatty liver disease - Google Patents WO2020097723A1 - Apple peel polyphenol …